EGFR and alopecia: Studies assessed capecitabine-induced hand-foot syndrome (HFS), multikinase inhibitor-induced hand-foot skin reaction (HFSR), taxane-induced alopecia, and epidermal growth factor receptor (EGFR) inhibitor-related skin toxicities.